𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quetiapine in anorexia nervosa patients: An open label outpatient pilot study

✍ Scribed by Powers, Pauline S. ;Bannon, Yvonne ;Eubanks, Rebecca ;McCormick, Terry

Publisher
Wiley (John Wiley & Sons)
Year
2006
Tongue
English
Weight
160 KB
Volume
40
Category
Article
ISSN
0276-3478

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

An open-label study of quetiapine in ano
An open-label study of quetiapine in anorexia nervosa
✍ P. Bosanac; S. Kurlender; T. Norman; K. Hallam; K. Wesnes; T. Manktelow; G. Burr πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 113 KB πŸ‘ 2 views

## Abstract ## Background Atypical antipsychotics may be beneficial in treating the core psychopathology of anorexia nervosa (AN). ## Methods An 8 week open‐label study of quetiapine was conducted in eight severely ill DSM‐IV AN patients consecutively admitted to a specialist eating disorders un

CQP 201-403 in Parkinson's disease: An o
CQP 201-403 in Parkinson's disease: An open-label pilot study
✍ Dr. Ronald F. Pfeiffer; Leonel H. Herrera; Carolyn S. Glaeske; Ruth E. Hofman πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 249 KB πŸ‘ 1 views

The dopamine agonist, CQP 201-403, was administered to 10 patients in an open label fashion with rapid dosage escalation during hospitalization. Assessed over a n average of 20 days, significant improvement occurred in bradykinesia, rigidity, and postural instability. Tremor did not occur in suffici

Ipsapirone in the treatment of bulimia n
Ipsapirone in the treatment of bulimia nervosa: An open pilot study
✍ Geretsegger, Christian ;Greimel, Karoline V. ;Roed, Llona S. ;Hesselink, Jan M. πŸ“‚ Article πŸ“… 1995 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 326 KB πŸ‘ 2 views

Seventeen women who met the criteria for bulimia nervosa (DSM-Ill-R) were treated for 4 weeks in an open trial with ipsapirone, a partial 5-HT,\* agonist. Bulimic symptoms diminished in 66.6% of the patients after only 7 week of treatment, 93.3% showed a reduction of more than 50% of weekly binge ea

Duloxetine in the treatment of irritable
Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study
✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal